Contact
searchSearch
HMP Global

Venous Disease: Features

Interview
Evaluating Superficial Venous Disease: When and How to Assess for Deep Venous Obstruction
02/02/2026
Gloria Salazar, MD, FSIR
Dr Salazar emphasizes the importance of maintaining a comprehensive, systems-based approach to venous assessment.
Dr Salazar emphasizes the importance of maintaining a comprehensive, systems-based approach to venous assessment.
Dr Salazar emphasizes the...
02/02/2026
Vascular Disease Management
Cees Wittens, MD
LINC 2026
A New Modular Approach to Venous Stenting With ALTA's Multi-Segmented, Tapered Design
01/26/2026
Cees Wittens, Emeritus Professor of Venous Surgery at Maastricht University Medical Center (UMC+, the Netherlands) and the European College of Phlebology (ECoP) shares information about the Venous Stent ALTA®.
Cees Wittens, Emeritus Professor of Venous Surgery at Maastricht University Medical Center (UMC+, the Netherlands) and the European College of Phlebology (ECoP) shares information about the Venous Stent ALTA®.
Cees Wittens, Emeritus Professor...
01/26/2026
Vascular Disease Management
Ger
LINC 2026
Tips and Tricks in IVC Reconstruction
01/26/2026
Gerard O’Sullivan, MD, elaborates on approaches shaped by common pitfalls in IVC reconstruction and their prevention.
Gerard O’Sullivan, MD, elaborates on approaches shaped by common pitfalls in IVC reconstruction and their prevention.
Gerard O’Sullivan, MD,...
01/26/2026
Vascular Disease Management
Interview
Are Lytic-Based Thrombectomy Devices Still Relevant?
01/12/2026
Nicolas J. Mouawad, MD, MPH, MBA
Nicolas J. Mouawad, MD, asks if lytic-based thrombectomy is still relevant and discusses how non–lytic-based therapies provide a better safety profile and lower bleeding risk.
Nicolas J. Mouawad, MD, asks if lytic-based thrombectomy is still relevant and discusses how non–lytic-based therapies provide a better safety profile and lower bleeding risk.
Nicolas J. Mouawad, MD, asks if...
01/12/2026
Vascular Disease Management
Case Report
Femoral Vein Reconstruction: A Complicated Case Example Treating Chronic Venous Disease With a Modified Gun-Sight Technique
12/02/2025
Matthew Tiede, MD
The author presents a case of common femoral vein occlusion in a patient with Klippel-Trénaunay syndrome.
The author presents a case of common femoral vein occlusion in a patient with Klippel-Trénaunay syndrome.
The author presents a case of...
12/02/2025
Vascular Disease Management
Video
Venous Thromboembolism: A Cost Analysis
10/15/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Clinical Editor Craig Walker, MD, comments on Mary Yost’s article, “The Cost of Venous Thromboembolism”.
In this video, Clinical Editor Craig Walker, MD, comments on Mary Yost’s article, “The Cost of Venous Thromboembolism”.
In this video, Clinical Editor...
10/15/2025
Vascular Disease Management
Clinical Editor's Corner
A Cost Analysis of Venous Thromboembolism Treatment
10/14/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Clinical Editor Dr Craig Walker comments on the article by Mary Yost, MBA, "The Cost of Venous Thromboembolism".
Clinical Editor Dr Craig Walker comments on the article by Mary Yost, MBA, "The Cost of Venous Thromboembolism".
Clinical Editor Dr Craig Walker...
10/14/2025
Vascular Disease Management
Original Contribution
The Cost of Venous Thromboembolism
10/02/2025
Mary L. Yost, MBA
Venous thromboembolism (VTE), a common and serious vascular condition, is associated with a substantial economic burden. This review provides on overview of the economic cost of VTE and the factors that drive costs.
Venous thromboembolism (VTE), a common and serious vascular condition, is associated with a substantial economic burden. This review provides on overview of the economic cost of VTE and the factors that drive costs.
Venous thromboembolism (VTE), a...
10/02/2025
Vascular Disease Management
Interview
The SAVVE Trial: Assessing the Safety and Efficacy of the VenoValve Device for Deep Venous Reflux
08/07/2025
Cassius Iyad Ochoa Chaar, MD, MPH, MS
Dr Chaar provides an overview of the Surgical Antireflux Venous Valve Endoprosthesis (SAVVE) trial, which assesses the safety and efficacy of the VenoValve device.
Dr Chaar provides an overview of the Surgical Antireflux Venous Valve Endoprosthesis (SAVVE) trial, which assesses the safety and efficacy of the VenoValve device.
Dr Chaar provides an overview of...
08/07/2025
Vascular Disease Management
ISET 2025 Pounce
ISET 2025
ISET 2025: The Pounce™ Venous Thrombectomy System—Power and Control for Removing Peripheral Venous Clot
05/29/2025
Sameh M. Sayfo, MD, MBA, FABVM; Pradeep K. Nair, MD, FACC, FSCAI; Nachiket J. Patel, MD, FACC, FACP, FSCAI
Dr. Sameh Sayfo, Dr. Pradeep K. Nair, and Dr. Nachiket Patel share cases demonstrating the Pounce™ Venous Thrombectomy System’s exceptional performance in removing fresh or organized clot from both lower and upper extremity veins.
Dr. Sameh Sayfo, Dr. Pradeep K. Nair, and Dr. Nachiket Patel share cases demonstrating the Pounce™ Venous Thrombectomy System’s exceptional performance in removing fresh or organized clot from both lower and upper extremity veins.
Dr. Sameh Sayfo, Dr. Pradeep K....
05/29/2025
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Cardiovascular Scientific Forum
AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance
02/03/2026
Physician-led Collaboration Reinforces Ongoing Regulatory Activity and Clinical Advancement Across the Cardiovascular Portfolio LATHAM, N.Y.--Feb. 3, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on...
Physician-led Collaboration Reinforces Ongoing Regulatory Activity and Clinical Advancement Across the Cardiovascular Portfolio LATHAM, N.Y.--Feb. 3, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on...
Physician-led Collaboration...
02/03/2026
Vascular Disease Management
thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
Acquisitions
Boston Scientific Announces Agreement to Acquire Penumbra, Inc.
01/15/2026
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
MARLBOROUGH, Mass. and ALAMEDA,...
01/15/2026
Cath Lab Digest
Peripheral Arterial Disease
CIS and Terrebonne General Are First in Louisiana to Use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter
01/09/2026
JANUARY 8, 2026 –HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter to...
JANUARY 8, 2026 –HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter to...
JANUARY 8, 2026 –HOUMA, LA...
01/09/2026
Vascular Disease Management
Radiation Safety
Rampart Launches SECURE Clinical Program to Advance Clinical Evidence for Next Generation Radiation Protection
01/08/2026
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
First-of-its-Kind,...
01/08/2026
Vascular Disease Management
Deep Venous Disease
Gore Gains FDA Approval for First Deep Venous Stent Indicated for the IVC and Iliofemoral Veins
01/06/2026
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
The GORE® VIABAHN® FORTEGRA...
01/06/2026
Vascular Disease Management
Neuro Intervention
Penumbra Receives CE Mark for MIDWAY and ACCESS25 Delivery Catheters in Europe
12/19/2025
MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.
MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.
MIDWAY 43 and MIDWAY 62 delivery...
12/19/2025
Vascular Disease Management
Thrombectomy
Study Finds CAVT (Computer-Assisted Vacuum Thrombectomy) Shortens Hospital Stay and May Ease Burden on Hospital Systems
12/16/2025
The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs. 
The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs. 
The research suggests that CAVT,...
12/16/2025
Cath Lab Digest
Intravascular Imaging
Philips Agrees to Acquire SpectraWAVE Inc., Advancing Next-Generation Coronary Intravascular Imaging and Physiological Assessment With AI
12/16/2025
Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled...
Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled...
Acquisition of SpectraWAVE’s...
12/16/2025
Vascular Disease Management
Acute Type A Dissection
Gore Announces First Patient Implant of the GORE® Ascending Stent Graft for Treatment of Acute Type A Dissection in ARISE III Pivotal Study
12/15/2025
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant...
12/15/2025
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use